Results 51 to 60 of about 17,663 (255)

Outcome of intracerebral hemorrhage associated with different oral anticoagulants [PDF]

, 2017
Objective: In an international collaborative multicenter pooled analysis, we compared mortality, functional outcome, intracerebral hemorrhage (ICH) volume, and hematoma expansion (HE) between non-vitamin K antagonist oral anticoagulation-related ICH ...
Ambler, Gareth, Basir, Ghazala, Boulanger, Marion, Choi, Philip M. C., Cordonnier, Charlotte, CROMIS-2 Collaborators, Dowlatshahi, Dar, Engelter, Stefan T., Ferrigno, Marc, Houben, Rik, Jaeger, Hans R., Jeng, Jiann-Shing, Meretoja, Atte, Parry-Jones, Adrian R., Perry, Luke A., Purrucker, Jan C., Rizos, Timolaos, Sallinen, Hanne, Salman, Rustam Al-Shahi, Schreuder, Floris H. B. M., Seiffge, David J., Shakeshaft, Clare, Sobowale, Oluwaseun A., Staals, Julie, Tanaka, Jun, Traenka, Christopher, Veltkamp, Roland, Werring, David J., Wilson, Duncan, Wu, Teddy Y., Yakushiji, Yusuke, Yeh, Shin-Joe   +31 more
core   +4 more sources

Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions [PDF]

Netherlands Heart Journal, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) are prescribed to patients with atrial fibrillation (AF) to reduce the risk of stroke. Prescribing the correct dose warrants careful consideration of the prevailing dose criteria that differ per NOAC. Electronic systems are useful to intercept prescriptions that are incorrect based on simple 'primary'
M. S. Jacobs, M. van Hulst, Z. Campmans, R. G. Tieleman   +3 more
openaire   +2 more sources

Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome [PDF]

, 2019
© The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the ...
Gorog, Diana A, Gue, Ying X, Kanji, Rahim, Srinivasan, Manivannan, Wellsted, David M, Wyatt, Solange   +5 more
core   +2 more sources

Non–Vitamin K Antagonist Oral Anticoagulants: The Clinician’s New Challenge

Journal of Osteopathic Medicine, 2015
Abstract Millions of US patients are prescribed oral anticoagulants. Traditionally, oral anticoagulation was achieved with vitamin K antagonists (VKAs). In recent years, non–VKA oral anticoagulants (NOACs) have emerged that provide an effective and convenient alternative to VKAs.
Brian K, Yorkgitis, Jeanette, Zhang, Joseph F, Rappold   +2 more
openaire   +2 more sources

Integration of Nutrition and Organic Agriculture Framework in Managing Gastrointestinal Nematodes in Ruminants

Animal Research and One Health, EarlyView.
Gastrointestinal nematode infections damage the gastrointestinal epithelial tissues of ruminants, affecting nutrient utilization and overall production performance. This review outlines host‐gastrointestinal nematode interactions and discusses integrated control strategies, including nutritional supplementation, grazing management, vaccines, and ...
Wenxun Chen, Xiangfang Tang, Yimin Zhuang, Shengjun Zhao, Ying Ren, Xiaokang Lv   +5 more
wiley   +1 more source

Preparation and Characterization of Isradipine as Surfactant-Free Dry Emulsion

مجلة كلية الطب
Background: Oral anticoagulation medication, warfarin, and non-vitamin K antagonist oral anticoagulants (NOAC) may require long-term use which may affect patients’ satisfaction with their treatment and their quality of life (QOL).
Zahraa M. Al-Sharify, Fatima J. Jawad
doaj   +1 more source

Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study [PDF]

, 2015
[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA oral anticoagulants (NOACs ...
Anguita-Sanchez, Manuel, Bertomeu-González, Vicente, Bertomeu-Martínez, Vicente, Castillo, Jesús, Cequier, Ángel, investigators of the FANTASIIA study, Marín, Francisco, Moreno-Arribas, José, Muñiz, Javier, Roldán, Inmaculada, Sanchis, Juan   +10 more
core   +2 more sources

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

TH Open, 2018
Background Vitamin K antagonists (VKAs) are associated with coronary artery calcification in low-risk populations, but their effect on calcification of large arteries remains uncertain.
Frederique E. C. M. Peeters, Elton A. M. P. Dudink, Dorien M. Kimenai, Bob Weijs, Sibel Altintas, Luuk I. B. Heckman, Casper Mihl, Leon J. Schurgers, Joachim E. Wildberger, Steven J. R. Meex, Bas L. J. H. Kietselaer, Harry J. G. M. Crijns   +11 more
doaj   +1 more source

Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation. [PDF]

, 2017
Nonvalvular atrial fibrillation (AF) is a risk factor for stroke in elderly patients. Although warfarin has been used to prevent AF-associated stroke for more than 50 years, non-vitamin K antagonist oral anticoagulants (NOACs) including dabigatran ...
Alexander, Ansell, Bathala, Camm, Connolly, Connolly, Eriksson, Giugliano, Goto, Granger, Harder, Heidbuchel, Hori, Hori, JCS Joint Working Group, Kimura, Matsushima, Mega, Mendell, Ogata, Ogawa, Oldgren, Oldgren, Patel, Sardar, Savelieva, Shen, Tanahashi, Tanigawa, Wong   +29 more
core   +1 more source